Law Offices of Howard G. Smith announces an investigation on behalf of SIGA Technologies, Inc. (“SIGA” or the “Company”) (NASDAQ: SIGA) investors concerning the Company’s possible violations of federal securities laws.

On September 23, 2024, after market hours, SIGA disclosed that its Chief Medical Officer and Executive Vice President, Dr. Jay Varma, had been terminated from his position. On this news, SIGA’s stock price fell $0.42, or 5%, to close at $8.01 per share on September 24, 2024, thereby injuring investors.

Then, on September 25, 2024, a secretly recorded video surfaced online, revealing Varma detailing a media “spin” campaign to salvage TPOXX as a treatment for Monkeypox so that investors wouldn’t “dump the stock, thinking that the Company is worthless,” despite the admission that “in the United States, the risk [for Monkeypox] is very low.” On this news, SIGA’s stock price fell $1.26, or 15.7%, to close at $6.75 per share on September 25, 2024, thereby injuring investors further.

If you purchased SIGA securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241002434631/en/